Wellgen Medical Invited to Thailand International Biotech Exhibition to Deliver Keynote on “Next-Generation Digital Cytology and Cancer Diagnostics”

Wellgen Medical was invited to participate in the Thailand International Biotech Exhibition, showcasing its latest innovations in smart healthcare and AI-powered medical imaging analysis to an international audience of industry leaders and researchers.

Dr. Eason Lin, Founder of Wellgen Medical, delivered a keynote speech titled "Next-Generation Digital Cytology and Cancer Diagnostics," sharing how Wellgen is pioneering the future of cancer diagnostics through digital cytology and AI technologies.

This marks a significant milestone in Wellgen's international expansion and highlights Taiwan's growing influence in the global biotechnology arena. Wellgen remains committed to driving a digital transformation in cancer detection and clinical applications through continuous technological innovation, further advancing its core mission of "AI-Assisted Diagnosis" on the world stage.